CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
94 hedge funds and large institutions have $105M invested in CureVac in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 11 closing their positions.
69% more capital invested
Capital invested by funds: $62.5M → $105M (+$42.9M)
29% more call options, than puts
Call options by funds: $848K | Put options by funds: $655K
27% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 11
3.59% more ownership
Funds ownership: 5.2% → 8.79% (+3.6%)
3% more funds holding
Funds holding: 91 → 94 (+3)
10% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$21.4M |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$5.13M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$3.54M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.87M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$1.36M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$1.09M |
| 3 |
WIC
Water Island Capital
New York
|
-$1.05M |
| 4 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
-$787K |
| 5 |
SOW
State of Wyoming
Cheyenne,
Wyoming
|
-$751K |
CVAC Hedge Fund Activity: Q3 2025 in Review
94 institutional investors reported a position in CureVac (CVAC) for Q3 2025, worth a combined $105M — up 69% from $62.5M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CVAC positions and 11 closed out — a net gain of 3 holders — while 26 added to existing stakes and 29 trimmed.
The largest buyer was Glazer Capital LLC, adding an estimated $21.4M. The largest seller was National Bank of Canada, cutting an estimated $1.36M.
- 94 institutional investors held CureVac (CVAC) as of Q3 2025, up from 91 in Q2 2025.
- Funds reported $105M of CureVac stock for Q3 2025, up 69% quarter-over-quarter.
- 14 funds opened new CureVac positions in Q3 2025 and 11 closed out, a net change of +3 holders.
- The largest CureVac buyer in Q3 2025 was Glazer Capital LLC, an estimated $21.4M added.
- The largest CureVac seller in Q3 2025 was National Bank of Canada, an estimated $1.36M sold.
Based on aggregated 13F filings for Q3 2025.